Tavaborole

Error creating thumbnail:

Tavaborole

Error creating thumbnail:

Tavaborole ball-and-stick model.png

Tavaborole is a topical antifungal medication used for the treatment of onychomycosis, a fungal infection of the nails. It is marketed under the brand name Kerydin. Tavaborole is notable for its ability to penetrate the nail plate and reach the site of infection, which is essential for effective treatment.

Mechanism of Action

Tavaborole works by inhibiting an essential fungal enzyme called leucyl-tRNA synthetase. This enzyme is crucial for the synthesis of fungal proteins. By inhibiting this enzyme, tavaborole disrupts protein synthesis, leading to fungal cell death.

Indications

Tavaborole is specifically indicated for the treatment of onychomycosis of the toenails caused by Trichophyton rubrum or Trichophyton mentagrophytes. It is applied topically to the affected nail(s) once daily for a period of 48 weeks.

Application

The medication is available as a 5% solution. Patients are advised to apply tavaborole to the entire surface of the affected toenail, including the undersurface of the nail tip, using the provided dropper. It is important to follow the prescribed duration of treatment to achieve optimal results.

Side Effects

Common side effects of tavaborole include application site exfoliation, erythema, and dermatitis. These side effects are generally mild and transient. However, patients should consult their healthcare provider if they experience severe or persistent side effects.

Clinical Studies

Clinical trials have demonstrated the efficacy of tavaborole in treating onychomycosis. In these studies, a significant percentage of patients achieved a complete or almost complete cure of their fungal infection after 48 weeks of treatment.

Comparison with Other Treatments

Tavaborole is one of several topical treatments available for onychomycosis. Other treatments include ciclopirox and efinaconazole. Compared to these treatments, tavaborole has shown a favorable safety profile and good efficacy in clinical trials.

Conclusion

Tavaborole is a valuable option for patients suffering from onychomycosis, offering a targeted approach to treating fungal infections of the toenails. Its unique mechanism of action and ability to penetrate the nail plate make it an effective treatment choice.

See Also

• Onychomycosis
• Antifungal
• Ciclopirox
• Efinaconazole

References

‎